https://orcid.org/0000-0001-5192-8659
About the Authors
- Mazin Abdelghany
-
Roles Conceptualization, Formal analysis, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing
* E-mail: mazin.abdelghany@mrc-bsu.cam.ac.uk
Affiliation Gilead Sciences, Inc., Foster City, California, United States of America
- Fang Yu
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
- Stephen Rennard
-
Roles Conceptualization, Methodology, Writing – review & editing
Affiliation Division of Pulmonary, Critical Care & Sleep Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
- Yeongjin Gwon
-
Roles Conceptualization, Methodology, Supervision, Writing – review & editing
Affiliation Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, United States of America
Competing Interests
MA is a former employee of Gilead Sciences, Inc. YG, SR, and FY have no conflicts of interest to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The PINETREE Phase 3 trial data, which we used for this analysis, was utilized for submission of regulatory updates to VEKLURY (remdesivir) prescribing information globally. VEKLURY (remdesivir) is a globally marketed product.